Date: 23 September- 28 October 2021
This course will provide academic and industry researchers working in drug discovery and development with a deep understanding of biopharmaceutical pricing and market access, while outlining the key early considerations which need to be made to allow the right treatment to get to the right patient, at the right time and at the right price. Understanding how basic and early translational research outcomes can impact industry go / no-go and commercial strategy decisions will allow a more holistic view of the challenges and potentials in the development of novel biopharmaceuticals.
Register for this 6 week virtual course to develop the knowledge and skills required to deliver a successful Life Science commercial strategy and become an industry leader. Sessions will take place once weekly (Thursdays 2-5pm) from 23 September – 28 October 2021 in this executive education programme developed by CATS and Windrose Consulting Group. Full details of the course can be found on the CATS website. There are a limited number of bursaries available for academics from the University of Cambridge to take part in Module 1 of this course. Interested academics should register their interest with cats@admin.cam.ac.uk with a short description of how this course would benefit their research and career.
